We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / Products & Services / Pharmaceuticals / Chromatography equipment / Purification of Peptides and Oligonucleotides / What are the challenges in chromatography for COVID-19 mRNA vaccine production?
What are the challenges in chromatography for COVID-19 mRNA vaccine production?
Pharmaceuticals

What are the challenges in chromatography for COVID-19 mRNA vaccine production?

 

Webinar

Webinar Chromatography Challenges For Covid 19 MRNA Vaccine Production Final

Duration:

15 minutes.

Abstract:

The new Sars Cov2 coronavirus pandemic has revolutionized traditional methods of vaccine development and production, taking advantage of a new mRNA-based technology to achieve unprecedented delivery schedules.

Once the mRNA vaccine design is completed, producing a pure tide requires various purification techniques, combining low pressure (LPLC) and high performance (HPLC) chromatography.

Speaker:

Jérôme Chevalier, Product Manager, Novasep Equipment Solutions.

 

 
 
Contact

A question ? A request ? Leave us a message !

Contact us
You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!